Showing results (221-230 of 858) with videos related to
Sort By:
Pageof 86
Expert Review of Clinical Pharmacology|November 14, 2012
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosisOscar Fernandez, Thomas Berger, Hans-Peter Hartung, et al.Journal of Medical Internet Research|June 12, 2025
Digital Mental Health Interventions for the Prevention and Treatment of Social Anxiety Disorder in Children, Adolescents, and Young Adults: Systematic Review and Meta-Analysis of Randomized Controlled TrialsNoemi Walder, Alessja Frey, Thomas Berger, et al.Pharmacological Reviews|May 8, 2024
Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple SclerosisGabriel Bsteh, Assunta Dal Bianco, Tobias Zrzavy, et al.Laryngo- Rhino- Otologie|June 6, 2020
[Auditory localisation in hearing impaired schoolchildren with and without hearing aids]Sylvia Meuret, Thomas Berger, Michael Fuchs, et al.Death Studies|October 29, 2021
Psychotherapists' rated working alliance in an internet-based intervention for bereaved siblingsRico-Benjamin Hiemeyer, Thomas Berger, Tina Braun, et al.The European Journal of Neuroscience|January 1, 1992
Sodium and Calcium Currents in Glial Cells of the Mouse Corpus Callosum SliceThomas Berger, Jutta Schnitzer, Paula M. Orkand, et al.Journal of Neuroinflammation|April 13, 2019
TNFα inhibitors as targets for protective therapies in MSA: a viewpointAlain Ndayisaba, Kurt Jellinger, Thomas Berger, et al.Internet Interventions|April 13, 2026
Therapist-guided online group forums in internet-based cognitive behavioral therapy for social anxiety disorder: A mixed-methods analysisAlina Kneubühler, Anna K Possehl, Ava Schulz, et al.Multiple Sclerosis and Related Disorders|March 17, 2020
Transient MOG antibody seroconversion associated with immunomodulating therapyMarc Pawlitzki, Christin Campe, Leoni Rolfes, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 29, 2010
Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease riskPeter Willeit, Johann Willeit, Anita Brandstätter, et al.Pageof 86